While this classification categorizes HCC and its corresponding histological features, unfortunately the most prevalent oncogenic drivers in HCC, such as TERT, TP53, CTNNB1, AXIN1, are currently ‘not actionable’, meaning they are not targetable by the currently available targeted treatments. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.